Vitamin B5, also called d-pantothenic acid,
is an essential
vitamin in the human body and is widely used in pharmaceuticals, nutritional
supplements, food, and cosmetics. However, few studies have investigated
the microbial production of d-pantothenic acid, especially
in Saccharomyces cerevisiae. By employing
a systematic optimization strategy, we screened seven key genes in d-pantothenic acid biosynthesis from diverse species, including
bacteria, yeast, fungi, algae, plants, animals, etc., and constructed
an efficient heterologous d-pantothenic acid pathway in S. cerevisiae. By adjusting the copy number of the
pathway modules, knocking out the endogenous bypass gene, balancing
NADPH utilization, and regulating the GAL inducible
system, a high-yield d-pantothenic acid-producing strain,
DPA171, which can regulate gene expression using glucose, was constructed.
By optimizing fed-batch fermentation, DPA171 produced 4.1 g/L d-pantothenic acid, which is the highest titer in S. cerevisiae to date. This study provides guidance
for the development of vitamin B5 microbial cell factories.